Eli Lilly (LLY) confirmed it agreed to buy Ventyx Biosciences (VTYX) for $14 a share in cash.
The deal has an aggregate equity value of about $1.2 billion, according to a statement on Wednesday. The transaction is not subject to
Eli Lilly confirms deal to buy Ventyx Biosciences for $14 a share
